Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

BACKGROUND: This randomized phase III study was to evaluate the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal carcinomatosis (PC) from gastric cancer. METHODS: Sixty-eight gastric PC patients were randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiao-Jun, Huang, Chao-Qun, Suo, Tao, Mei, Lie-Jun, Yang, Guo-Liang, Cheng, Fu-Lin, Zhou, Yun-Feng, Xiong, Bin, Yonemura, Yutaka, Li, Yan
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087875/
https://www.ncbi.nlm.nih.gov/pubmed/21431408
http://dx.doi.org/10.1245/s10434-011-1631-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087875/
https://www.ncbi.nlm.nih.gov/pubmed/21431408
http://dx.doi.org/10.1245/s10434-011-1631-5

Ejemplares similares